The molecular aspects of personalized anticancer treatment; AIP Conference Proceedings; Vol. 1760 : Physics of Cancer: Interdisciplinary Problems and Clinical Applications 2016

Manylion Llyfryddiaeth
Parent link:AIP Conference Proceedings
Vol. 1760 : Physics of Cancer: Interdisciplinary Problems and Clinical Applications 2016.— 2016.— [020010, 5 p.]
Awdur Corfforaethol: Национальный исследовательский Томский политехнический университет (ТПУ) Институт кибернетики (ИК) Кафедра оптимизации систем управления (ОСУ)
Awduron Eraill: Cherdyntseva N., Litviakov N., Ivanova F., Denisov E., Gervas P., Cherdyntsev E. S. Evgeny Sergeevich
Crynodeb:Title screen
Only 25% of cancer patients, on average, benefit from therapy. Even in the cases of complete clinical response the tumor progression is an event of high level expectation. The main reasons for tumor progression are: intratumor heterogeneity resulted from clonal evolution, drug resistance, and tumor-promoting microenvironment. The reprogramming of microenvironmental stromal-inflammatory components is expected to allow tumor phenotype reversion. So, to find the new effective markers of tumor progression, drug response and targets for therapy, it could be promising to take into account the tumor-microenvironment heterogeneity and tumor clonal evolution.
Режим доступа: по договору с организацией-держателем ресурса
Iaith:Saesneg
Cyhoeddwyd: 2016
Pynciau:
Mynediad Ar-lein:http://dx.doi.org/10.1063/1.4960229
http://earchive.tpu.ru/handle/11683/35803
Fformat: Electronig Pennod Llyfr
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=651979

MARC

LEADER 00000nla2a2200000 4500
001 651979
005 20231225085902.0
035 |a (RuTPU)RU\TPU\network\17242 
035 |a RU\TPU\network\17241 
090 |a 651979 
100 |a 20161129a2016 k y0engy50 ba 
101 0 |a eng 
105 |a y z 100zy 
135 |a drgn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a The molecular aspects of personalized anticancer treatment  |f N. Cherdyntseva [et al.] 
203 |a Text  |c electronic 
300 |a Title screen 
320 |a [References: 18 tit.] 
330 |a Only 25% of cancer patients, on average, benefit from therapy. Even in the cases of complete clinical response the tumor progression is an event of high level expectation. The main reasons for tumor progression are: intratumor heterogeneity resulted from clonal evolution, drug resistance, and tumor-promoting microenvironment. The reprogramming of microenvironmental stromal-inflammatory components is expected to allow tumor phenotype reversion. So, to find the new effective markers of tumor progression, drug response and targets for therapy, it could be promising to take into account the tumor-microenvironment heterogeneity and tumor clonal evolution. 
333 |a Режим доступа: по договору с организацией-держателем ресурса 
461 0 |0 (RuTPU)RU\TPU\network\4816  |t AIP Conference Proceedings 
463 0 |0 (RuTPU)RU\TPU\network\17033  |t Vol. 1760 : Physics of Cancer: Interdisciplinary Problems and Clinical Applications 2016  |o Proceedings of the International conference, 22-25 March 2016, Tomsk, Russia  |f National Research Tomsk Polytechnic University (TPU) ; eds. E. Y. Gutmanas ; O. B. Naimark ; Yu. P. Sharkeev  |v [020010, 5 p.]  |d 2016 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a лечение 
610 1 |a рак 
610 1 |a опухоли 
610 1 |a терапия 
610 1 |a гетерогенность 
610 1 |a эффективность 
610 1 |a токсичность 
701 1 |a Cherdyntseva  |b N. 
701 1 |a Litviakov  |b N. 
701 1 |a Ivanova  |b F. 
701 1 |a Denisov  |b E. 
701 1 |a Gervas  |b P. 
701 1 |a Cherdyntsev  |b E. S.  |c specialist in the field of informatics and computer technology  |c Associate Professor of Tomsk Polytechnic University, candidate of technical sciences  |f 1953-  |g Evgeny Sergeevich  |3 (RuTPU)RU\TPU\pers\36884  |9 19913 
712 0 2 |a Национальный исследовательский Томский политехнический университет (ТПУ)  |b Институт кибернетики (ИК)  |b Кафедра оптимизации систем управления (ОСУ)  |3 (RuTPU)RU\TPU\col\18702 
801 2 |a RU  |b 63413507  |c 20170120  |g RCR 
856 4 |u http://dx.doi.org/10.1063/1.4960229 
856 4 |u http://earchive.tpu.ru/handle/11683/35803 
942 |c CF